NCT06396819View on ClinicalTrials.gov

Collagen-povidone for Diabetic Seniors' Tenosynovitis

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

January 1, 2024

Study Completion Date

April 1, 2024

Conditions
Diabetes Complications
Interventions
DRUG

collagen-povidone solution

Application of collagen-povidone solution at a dose of 0.2 cc, compared with the application of physiological solution in the control group

Trial Locations (1)

44329

Unidad de Investigación Biomédica 02, Unidad Médica de alta especialidad, Hospital de Especialidades Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara 44329, Mexico, Guadalajara

All Listed Sponsors
lead

Instituto Mexicano del Seguro Social

OTHER_GOV